What is Daiichi Sankyo's contact information?

Daiichi Sankyo's contact information: +81362251111.

How many employees does Daiichi Sankyo have?

Daiichi Sankyo has 1,400 employees.

What industry does Daiichi Sankyo belong to?

Daiichi Sankyo is in the industry of: Pharmaceuticals, Pharmaceutical Manufacturing, Health Care & Social Assistance.

What are Daiichi Sankyo's official social media profiles?

Daiichi Sankyo Linkedin Page Daiichi Sankyo Facebook Page Daiichi Sankyo Twitter Page

What tech stack does Daiichi Sankyo use?

Some of the popular technologies that Daiichi Sankyo uses are: Linkedin Ads, Linkedin Insight Tag, DNN.

What are Daiichi Sankyo's office addresses?

Daiichi Sankyo has 2 known office addresses: 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo Tokyo, 103-8426, JP Munich, DE.

What is Daiichi Sankyo's estimated annual revenue?

Daiichi Sankyo's revenue is $8,526,532,000

What is Daiichi Sankyo's open headcount?

Daiichi Sankyo has 36 job postings.

What is the number of ad campaigns for Daiichi Sankyo?

Daiichi Sankyo has no advertisements yet.

What is the number of recent news articles about Daiichi Sankyo?

Daiichi Sankyo has 34 news articles.

Daiichi Sankyo - Pubrio Company Profile & Intent

Daiichi Sankyo

Japan · Pharmaceutical Manufacturing

Pharmaceuticals

Pharmaceutical Manufacturing

Health Care & Social Assistance

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com.

Company Insights

docdocdoc.co.kr · launches · 2 weeks ago

Open news

Enhertu reshapes HER2-low metastatic breast cancer treatment

Enhertu expands to HER2-low breast cancer, showing 13.2 months mPFS in DESTINY-Breast06 trial. It redefines HER2 classification and treatment strategies for metastatic breast cancer.

Astrazeneca

Daiichi Sankyo

청년의사

prnasia.com · partners_with · 2026-02-02

Open news

ACROBiosystems partners at BIOSeedin Innovation Summit

ACROBiosystems participated in BIOSeedin Winter Innovation Partnering Summit, focusing on global matching of innovative assets and fostering collaborations in the biopharmaceutical industry.

Acrobiosystems

Roche

Gsk

Bayer

Eli Lilly And Company

Daiichi Sankyo

Takeda

Fangda Partners

Bioseedin

Hengrui Pharma Co.,Ltd

Abbott Healthcare

Boehringer Ingelheim

Pfizer

prnasia.com · receives_award · 2026-01-22

Open news

Enhertu approved for HER2+ gastric cancer in China

Enhertu approved in China for HER2-positive gastric cancer, showing significant OS improvement in DESTINY-Gastric04 trial compared to standard treatment.

New England Journal Of Medicine

Astrazeneca

Daiichi Sankyo

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

Coindesk

Deribit

khgames.co.kr · is_developing · one week ago

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

Coindesk

Upbit Singapore

coinreaders.com · launches · one week ago

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Coindesk

J.P. Morgan

Get full access to view complete information

1 - 25 of 34

Frequently Asked Questions Regarding Daiichi Sankyo

Company Overview

2005

Founded

Pharmaceutical Manufacturing

Industry

Japan

Location

72,118

Ranking

1,400 employees

Size

Similar Companies

Get full access to view complete information